Vascular Stress Markers Following Inhalation of Heated Tobacco Products: A Study on Extracellular Vesicles

Cardiovasc Toxicol. 2025 Jan;25(1):1-8. doi: 10.1007/s12012-024-09934-6. Epub 2024 Oct 29.

Abstract

The advent of heated tobacco products (HTPs) has introduced new variables in the study of nicotine delivery systems and their health implications. Amidst concerns over cardiovascular effects, this study aims to elucidate the acute impact of HTP inhalation on extracellular vesicles (EV) levels in young, healthy individuals. In this controlled, acute exposure study, 23 young, healthy volunteers were subjected to HTP inhalation. EV levels of endothelial and platelet origin were quantified through flow cytometry before and after exposure. Data analysis was performed using multiple measures ANOVA to assess changes in EV concentrations. Our findings reveal a significant increase in EVs of endothelial and platelet origin following short-term HTP inhalation with nicotine. Notably, no significant change was observed in leukocyte- and neutrophil-derived EVs. This increase in EVs suggests acute vascular stress, with peak levels observed 4 h post-exposure. The rise in endothelial and platelet-derived EVs aligns with documented responses to acute vascular injury, paralleling the effects seen with traditional cigarette and e-cigarette use. Despite HTPs being marketed as safer alternatives, our results indicate that nicotine-containing HTPs may still pose significant vascular risks. These findings contribute to the growing body of evidence cautioning against the perceived safety of HTPs and reinforce the importance of regulatory oversight and public health initiatives targeting nicotine delivery technologies. Trial Registrations: ClinicalTrials.gov ID: NCT04824495, registered 2021-01-07.

Keywords: Endothelial function; Extracellular vesicles; Heat not burn products; Heated tobacco products; Microvesicles; Nicotine.

MeSH terms

  • Administration, Inhalation
  • Adult
  • Biomarkers / blood
  • Blood Platelets* / drug effects
  • Blood Platelets* / metabolism
  • Electronic Nicotine Delivery Systems
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism
  • Endothelial Cells / pathology
  • Extracellular Vesicles* / drug effects
  • Extracellular Vesicles* / metabolism
  • Female
  • Healthy Volunteers
  • Hot Temperature*
  • Humans
  • Male
  • Nicotine* / administration & dosage
  • Nicotine* / toxicity
  • Nicotinic Agonists / administration & dosage
  • Nicotinic Agonists / toxicity
  • Risk Assessment
  • Time Factors
  • Tobacco Products* / adverse effects
  • Young Adult

Substances

  • Nicotine
  • Nicotinic Agonists
  • Biomarkers

Associated data

  • ClinicalTrials.gov/NCT04824495